Daniel Grossman, MD, is ANSIRH's Director. He focuses his research on both clinical and social science studies aimed at improving access to contraception and safe abortion in the United States, Latin America, and sub-Saharan Africa, as well as evaluating the impact of integrating reproductive health and HIV services. He has served on committees for professional organizations such as the American Public Health Association and the American College of Obstetricians and Gynecologists. As a faculty member in the Department of Obstetrics, Gynecology and Reproductive Sciences at UCSF, Dr. Grossman performs clinical work at Zuckerberg San Francisco General Hospital. He is also a Senior Advisor with Ibis Reproductive Health. Dr. Grossman received his Bachelor of Science in Molecular Biophysics and Biochemistry from Yale University and an MD from Stanford University. He completed his residency in Obstetrics and Gynecology at UCSF.
September 16, 2021
Thompson TA, Seymour JW, Melville C, Khan Z, Danielle Mazza, Grossman D. An observational study of patient experiences with a direct-to-patient telehealth abortion model in Australia. BMJ Sexual & Reproductive Health. September 2021; doi: 10.1136/bmjsrh-2021-201259.
July 19, 2021
Dickman SL, Kari White, Grossman D. Affordability and Access to Abortion Care in the United States. JAMA Internal Medicine. July 2021; [Epub ahead of print].
May 25, 2021
Potter JE, Burke KL, Broussard K, Hopkins K, Grossman D, Kari White. Improving Assessment of Demand for Postpartum Tubal Ligation among Publicly Insured Women in Texas. Contraception. May 2021; S0010-7824(21)00156-6. [Epub ahead of print].